Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...

LONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun ...

Listen to this article Pharmaceutical company Haleon will invest $54.2 million to upgrade its research and development facility in Richmond and launch an internship program in partnership with state ...

Ltd., known as INSEE Cement, Sri Lanka’s leading and only fully integrated cement manufacturer, has announced the appointment ...

U.K. stocks are slightly down Monday morning, due largely to weakness in the mining sector after data showed a contraction in the ...

BOCA RATON, FL, UNITED STATES, January 27, 2025 /EINPresswire / -- With rising business confidence indicators from Moody's and The Nationa ...

The European Laboratory Research & Innovation Group (ELRIG), a not-for-profit, volunteer-led organisation for the drug discovery community, today announced the keynote speakers for Research & ...

GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...

First-line treatment with targeted therapies plus chemotherapy offered overall response benefits in BRAF V600E-mutant ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.